2016 Drug Design and Delivery Symposium

We’ve expanded our panel of experts and revamped the format of the symposium for 2016. This year’s webinar series has been divided in to different modules in order to provide three short, comprehensive perspectives of the drug design and delivery process. Register now to discover more about:

I - Time: The Fourth Dimension in Drug Discovery
January 28	The Importance of Drug-Target Kinetics in Drug Design Robert Copeland - Epizyme, Inc Dan Erlanson - Carmot Therapeutics
February 25	Long-Acting Injectable Medications: Strategies and Mechanistic Considerations Jules Remenar - Alkermes Annette Bak - Merck
March 31	Modified Release Formulations for Solubility Starved Compounds Mengwei Hu - Merck John Morrison - BMS
April 28	The Medicinal Chemist of Tomorrow (Special Topic) Joel Barrish - Achillion Ravi Nargund - Merck Molly Schmid - Tech Coast Angels
II - Beyond Traditional Small Molecules
May 19	Design of Deliverable Macrocycles Scott Lokey - UC Santa Cruz Nicholas Meanwell - BMS
June 23	Dreaming Big and Thinking Small: Applying Medicinal Chemistry Strategy to Antibody-Drug-Conjugates L. Nathan Tumey - Pfizer Peter Senter - Seattle Genetics
July 28	Nucleic Acids Therapeutics: Making Sense of Antisense Oligonucleotides Punit Seth - Ionis Richard Olson - BMS
August 18	Crystallography as a Drug Design and Delivery Tool (Special Topic) Robert Wenslow - Crystal Pharmatech Vincent Stoll - Abbvie Andrew Brunskill - Merck
III - Pharmacology Revisited
September 29	Dealing with Reactive Drug Metabolites in Drug Discovery: Can We Predict Toxicities of Drug Candidates that form Reactive Metabolites? Deepak Dalvie - Pfizer Frederick Peter Guengerich - Vanderbilt University
October 27	Rational Design of Small Molecules Targeting RNA Matt Disney - Scripps RI Florida Amanda Garner - University of Michigan
November 10	Cell Penetrating Peptides to Improve Cellular Drug Uptake Dehua Pei - The Ohio State University Scott Hart - Bristol-Myers Squibb